As countries look for ways to recover quickly from the economic damage caused by the outbreak, researchers have so far failed to agree on the speed of the new crown vaccine, which is expected to take place in January and even this fall. John Bell, a professor of medicine at the University of Oxford, said on Sunday that British scientists were hoping for “signals” by June on the effectiveness of the vaccine candidate.
Bell said on NBC’s “Meet the Press” that the vaccine is “very likely” to be available within a year. However, he played down colleagues’ claimthat the probability was 80 per cent. Typically, vaccines take at least a few years to develop.
The UK will co-host a conference on Monday to encourage countries to co-develop vaccines. The UK has pledged to invest 388 million pounds ($484 million) in the international vaccine program.
The White House last week announced an initiative called Operation Warp Speed to speed up the development of vaccines and provide many Americans with adequate doses in January. According to NBC News, there are about 14 vaccine candidates currently tested, which have since been reduced to six to eight.
Dr. Deborah Birx, a member of the White House’s Coronary Virus Task Force, said it was “on the face of it” that it was possible to achieve this unusually rapid goal.
“The premise is to screen out five to six different categories of vaccine candidates,” Birx said on “Fox News Sunday.” “
Trump administration launches “Trump Speed Action” to launch new crown vaccine by end of year
“Then there is the one phase, the second phase, the third phase of the trial, which continues to advance with good safety and immunogenicity data, without the usual pause in vaccine development,” she said.
Scott Gottlieb, a former director of the U.S. Food and Drug Administration, said the vaccine could be available in the fall “while further testing is ongoing” to ensure there are enough doses to prevent infections from occurring in cities.
Gottlieb predicts on CBS’s “Face The Nation” that by then several manufacturers will “pass early safety trials and be able to deploy millions of doses of vaccine production in large-scale studies.”
There are now more than 1.15 million new crown-confirmed cases and more than 67,000 deaths in the United States.
In the U.S., there are about 20,000 to 30,000 new infections and more than 1,000 deaths a day, which will be the “new normal” in the coming months, Gottlieb said. By the end of June, the death toll could reach 100,000.
Bell, of Oxford University, says the new crown vaccine, once successful, could be given every year, just as millions of people around the world get the seasonal flu vaccine every year.
“As far as we know, the new coronavirus doesn’t mutate as fast as the flu virus,” Bell said. But in terms of its long-term immune response, it is a very cunning virus. In the future, we may need to be vaccinated against the new coronavirus on a regular basis. “